+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Tumor Ablation Market by Technology (Cryoablation, High-Intensity Focused Ultrasound, Irreversible Electroporation Ablation), Treatment (Laparoscopic Ablation, Percutaneous Ablation, Surgical Ablation), Indication - Forecast 2024-2030- Product Image
Global Tumor Ablation Market by Technology (Cryoablation, High-Intensity Focused Ultrasound, Irreversible Electroporation Ablation), Treatment (Laparoscopic Ablation, Percutaneous Ablation, Surgical Ablation), Indication - Forecast 2024-2030- Product Image
Sale

Global Tumor Ablation Market by Technology (Cryoablation, High-Intensity Focused Ultrasound, Irreversible Electroporation Ablation), Treatment (Laparoscopic Ablation, Percutaneous Ablation, Surgical Ablation), Indication - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4985926
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Tumor Ablation Market size was estimated at USD 1.78 billion in 2023, USD 2.01 billion in 2024, and is expected to grow at a CAGR of 13.85% to reach USD 4.42 billion by 2030.

Tumor ablation is a minimally invasive surgical method used for the treatment of tumors within various organs of the body. This procedure involves directing heat, cold, or chemical agents directly into a tumor to destroy cancer cells without necessitating large incisions. It is commonly employed in the treatment of liver, kidney, bone, and lung cancers, among others. However, the technique may not always be effective for larger tumors or for tumors that are close to critical structures or organs, as there is a risk of damaging these areas. Additionally, there may be complications such as bleeding, infection, or damage to the surrounding tissues.

Addressing these concerns involves ongoing research into improving the precision of ablation techniques, developing better imaging technology to guide the procedures, and enhancing the training of medical professionals performing ablations. Advances in artificial intelligence and machine learning could lead to improved precision and outcomes of ablation procedures. Furthermore, the increasing prevalence of cancer worldwide and the rising demand for minimally invasive treatments are likely to drive the adoption of tumor ablation.

Regional Insights

In the Americas, there is a high adoption rate of advanced tumor ablation technologies, supported by strong healthcare infrastructure and favorable reimbursement policies. The region is home to leading companies that develop and manufacture cutting-edge ablation devices, contributing significantly to the global market share. The APAC region is witnessing rapid growth in the use of tumor ablation, driven by increasing healthcare expenditure, rising cancer prevalence, and growing awareness of minimally invasive treatments among patients and healthcare providers. Although APAC's production capabilities are expanding, the market is still in the process of catching up to the technical and regulatory standards prevalent in Western markets.

Several local players are emerging, but the market is also attractive for global companies looking to expand their geographic presence. EMEA presents a diverse scenario where advanced healthcare systems in Western Europe offer a solid ground for the adoption of tumor ablation technologies mirrored by robust regulatory frameworks. Companies operating in the EMEA region are a mix of established global players and smaller, region-specific companies navigating the complex regulatory and market landscape to ensure the availability of tumor ablation therapies.

Market Trends by Segment

  • Treatment: Exponential use of laparoscopic ablation for patients requiring minimally invasive surgery
  • Indication: Increasing research in using tumor ablation for treating lung cancer

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Medtronic Elevates Bone Tumor Treatment with FDA-Approved OsteoCool 2.0 System

Medtronic has been granted FDA 510(k) clearance for its advanced OsteoCool 2.0 bone tumor ablation system, marking a significant achievement in the treatment of painful bone metastases and benign bone tumors, including osteoid osteoma. Slated for a phased market introduction, starting with a limited release and followed by a nationwide launch later this year, the OsteoCool 2.0 system signifies a technological leap from its predecessor.

BioTraceIO receives FDA Approval for Ultrasound-Based BioTraceIO

Techsomed Medical Technologies LTD has achieved a significant milestone with the FDA's De Novo clearance of BioTraceIO, an ultrasound-based liver ablation software for tissue response prediction. This tool stands out as the sole FDA-cleared solution in its category, designed to enhance the efficacy of liver tumor ablations.

FDA Grants Breakthrough Designation to Vanquish Water Vapor Ablation Therapy by Francis Medical, Inc.

Francis Medical, Inc., a medical device firm, has achieved a significant milestone in cancer treatment with the U.S. Food and Drug Administration’s (FDA) breakthrough device designation for its Vanquish water vapor ablation therapy. This designation is aimed at expediting the development and review of novel technologies that promise a more effective treatment or diagnosis for severe or irreversibly debilitating diseases.

Key Company Profiles

The report delves into recent significant developments in the Tumor Ablation Market, highlighting leading vendors and their innovative profiles. These include Angiodynamics, Inc., Bioventus LLC., Boston Scientific Corp., BVM Medical Limited, Chongqing Haifu Medical Technology Co., Ltd., CONMED Corporation, CooperSurgical, Inc., Erbe Elektromedizin GmbH, IceCure Medical Ltd., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Mermaid Medical A / S, Smith & Nephew PLC, and Theraclion S. A.

This research report offers invaluable insights into various crucial aspects of the Tumor Ablation Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of cancer and need for effective treatments
5.1.1.2. Increasing shift to minimally invasive surgeries to remove tumors
5.1.1.3. Improvements in reimbursement policies for advanced cancer treatments
5.1.2. Restraints
5.1.2.1. Complexity of designing tumor ablation devices
5.1.3. Opportunities
5.1.3.1. Advancements in tumor ablation technologies worldwide
5.1.3.2. Favorable government approvals for tumor ablation
5.1.4. Challenges
5.1.4.1. Concerns associated with quality and safety of the device
5.2. Market Segmentation Analysis
5.2.1. Treatment: Exponential use of laparoscopic ablation for patients requiring minimally invasive surgery
5.2.2. Indication: Increasing research in using tumor ablation for treating lung cancer
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Tumor Ablation Market, by Technology
6.1. Introduction
6.2. Cryoablation
6.3. High-Intensity Focused Ultrasound
6.4. Irreversible Electroporation Ablation
6.5. Laser Interstitial Thermal Ablation
6.6. Microwave Ablation
6.7. Radiofrequency Ablation
7. Tumor Ablation Market, by Treatment
7.1. Introduction
7.2. Laparoscopic Ablation
7.3. Percutaneous Ablation
7.4. Surgical Ablation
8. Tumor Ablation Market, by Indication
8.1. Introduction
8.2. Breast Cancer
8.3. Kidney Cancer
8.4. Liver Cancer
8.5. Lung Cancer
8.6. Prostate Cancer
9. Americas Tumor Ablation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Tumor Ablation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Tumor Ablation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Medtronic Elevates Bone Tumor Treatment with FDA-Approved OsteoCool 2.0 System
12.3.2. BioTraceIO receives FDA Approval for Ultrasound-Based BioTraceIO
12.3.3. FDA Grants Breakthrough Designation to Vanquish Water Vapor Ablation Therapy by Francis Medical, Inc.
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. TUMOR ABLATION MARKET RESEARCH PROCESS
FIGURE 2. TUMOR ABLATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL TUMOR ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TUMOR ABLATION MARKET DYNAMICS
FIGURE 7. GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 10. GLOBAL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. TUMOR ABLATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. TUMOR ABLATION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. TUMOR ABLATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL TUMOR ABLATION MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL TUMOR ABLATION MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL TUMOR ABLATION MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL TUMOR ABLATION MARKET SIZE, BY CRYOABLATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL TUMOR ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL TUMOR ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL TUMOR ABLATION MARKET SIZE, BY IRREVERSIBLE ELECTROPORATION ABLATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL TUMOR ABLATION MARKET SIZE, BY IRREVERSIBLE ELECTROPORATION ABLATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL TUMOR ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL ABLATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL TUMOR ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL ABLATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL TUMOR ABLATION MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL TUMOR ABLATION MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL TUMOR ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL TUMOR ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL TUMOR ABLATION MARKET SIZE, BY LAPAROSCOPIC ABLATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL TUMOR ABLATION MARKET SIZE, BY LAPAROSCOPIC ABLATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL TUMOR ABLATION MARKET SIZE, BY PERCUTANEOUS ABLATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL TUMOR ABLATION MARKET SIZE, BY PERCUTANEOUS ABLATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL TUMOR ABLATION MARKET SIZE, BY SURGICAL ABLATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL TUMOR ABLATION MARKET SIZE, BY SURGICAL ABLATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL TUMOR ABLATION MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL TUMOR ABLATION MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL TUMOR ABLATION MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL TUMOR ABLATION MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL TUMOR ABLATION MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL TUMOR ABLATION MARKET SIZE, BY LIVER CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL TUMOR ABLATION MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL TUMOR ABLATION MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL TUMOR ABLATION MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL TUMOR ABLATION MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 61. CANADA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 62. CANADA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 63. CANADA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 64. CANADA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 65. CANADA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 66. CANADA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 67. MEXICO TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 68. MEXICO TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 69. MEXICO TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 70. MEXICO TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 71. MEXICO TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 72. MEXICO TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 86. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 89. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 90. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 91. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 92. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 93. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 94. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 95. CHINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 96. CHINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 97. CHINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 98. CHINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 99. CHINA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 100. CHINA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 101. INDIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 102. INDIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 103. INDIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 104. INDIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 105. INDIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 106. INDIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 107. INDONESIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 108. INDONESIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 109. INDONESIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 110. INDONESIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 111. INDONESIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 112. INDONESIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 113. JAPAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 114. JAPAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 115. JAPAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 116. JAPAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 117. JAPAN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 118. JAPAN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 119. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 120. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 121. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 122. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 123. MALAYSIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 124. MALAYSIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 125. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 126. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 127. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 128. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 129. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 130. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 131. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 132. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 133. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 134. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 135. SINGAPORE TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 136. SINGAPORE TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 137. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 138. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 139. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 140. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 141. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 142. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 143. TAIWAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 144. TAIWAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 145. TAIWAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 146. TAIWAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 147. TAIWAN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 148. TAIWAN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 149. THAILAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 150. THAILAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 151. THAILAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 152. THAILAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 153. THAILAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 154. THAILAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 155. VIETNAM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 156. VIETNAM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 157. VIETNAM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 158. VIETNAM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 159. VIETNAM TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 160. VIETNAM TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 169. DENMARK TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 170. DENMARK TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 171. DENMARK TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 172. DENMARK TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 173. DENMARK TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 174. DENMARK TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 175. EGYPT TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 176. EGYPT TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 177. EGYPT TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 178. EGYPT TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 179. EGYPT TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 180. EGYPT TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 181. FINLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 182. FINLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 183. FINLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 184. FINLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 185. FINLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 186. FINLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 187. FRANCE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 188. FRANCE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 189. FRANCE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 190. FRANCE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 191. FRANCE TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 192. FRANCE TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 193. GERMANY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 194. GERMANY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 195. GERMANY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 196. GERMANY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 197. GERMANY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 198. GERMANY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 199. ISRAEL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 200. ISRAEL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 201. ISRAEL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 202. ISRAEL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 203. ISRAEL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 204. ISRAEL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 205. ITALY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 206. ITALY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 207. ITALY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 208. ITALY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 209. ITALY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 210. ITALY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 211. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 212. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 213. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 214. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 215. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 216. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 217. NIGERIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 218. NIGERIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 219. NIGERIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 220. NIGERIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 221. NIGERIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 222. NIGERIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 223. NORWAY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 224. NORWAY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 225. NORWAY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 226. NORWAY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 227. NORWAY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 228. NORWAY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 229. POLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 230. POLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 231. POLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 232. POLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 233. POLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 234. POLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 235. QATAR TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 236. QATAR TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 237. QATAR TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 238. QATAR TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 239. QATAR TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 240. QATAR TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 241. RUSSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 242. RUSSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 243. RUSSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 244. RUSSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 245. RUSSIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 246. RUSSIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 248. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 250. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 252. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 254. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 256. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 258. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 259. SPAIN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 260. SPAIN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 261. SPAIN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 262. SPAIN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 263. SPAIN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 264. SPAIN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 265. SWEDEN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 266. SWEDEN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 267. SWEDEN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 268. SWEDEN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 269. SWEDEN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 270. SWEDEN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 271. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 272. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 273. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 274. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 275. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 276. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 277. TURKEY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 278. TURKEY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 279. TURKEY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 280. TURKEY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 281. TURKEY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 282. TURKEY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 290. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 292. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 294. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 295. TUMOR ABLATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 296. TUMOR ABLATION MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Angiodynamics, Inc.
  • Bioventus LLC.
  • Boston Scientific Corp.
  • BVM Medical Limited
  • Chongqing Haifu Medical Technology Co., Ltd.
  • CONMED Corporation
  • CooperSurgical, Inc.
  • Erbe Elektromedizin GmbH
  • IceCure Medical Ltd.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Mermaid Medical A / S
  • Smith & Nephew PLC
  • Theraclion S. A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.01 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.42 Billion
Compound Annual Growth Rate13.8%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Global Tumor Ablation Market Size, Share & Trends Analysis Report by Technology (Microwave, HIFU), Treatment (Laparoscopic Ablation, Percutaneous Ablation), Application (Liver Cancer, Lung Cancer), and Segment Forecasts, 2024-2030 - Product Image

Global Tumor Ablation Market Size, Share & Trends Analysis Report by Technology (Microwave, HIFU), Treatment (Laparoscopic Ablation, Percutaneous Ablation), Application (Liver Cancer, Lung Cancer), and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Tumor Ablation Market Report by Technology, Mode of Treatment, Mode of Application, End-User, and Region 2024-2032 - Product Image

Tumor Ablation Market Report by Technology, Mode of Treatment, Mode of Application, End-User, and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From
Tumor Ablation Therapy Devices Global Market Report 2024 - Product Image

Tumor Ablation Therapy Devices Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Tumor Ablation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Tumor Ablation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Tumor Ablation Technologies - Global Strategic Business Report - Product Image

Tumor Ablation Technologies - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From

About the Tumor Ablation Market

Tumor Ablation is a minimally invasive surgical procedure used to treat tumors. It involves the use of heat, cold, or other energy sources to destroy cancerous cells. The procedure is typically performed using a needle, probe, or catheter inserted into the tumor. It is often used to treat tumors that are too small or too deep to be removed surgically. It can also be used to treat tumors that have spread to other parts of the body. Tumor Ablation is a relatively new procedure and is becoming increasingly popular due to its minimally invasive nature and its ability to treat tumors that are difficult to remove surgically. It is also a cost-effective alternative to more traditional treatments such as chemotherapy and radiation. Some of the companies in the Tumor Ablation market include AngioDynamics, Medtronic, Boston Scientific, and Stryker. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.